Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jun;4(12):244.
doi: 10.21037/atm.2016.05.60.

Burden of costs associated with heparin-induced thrombocytopenia: is time to remove unfractionated heparin from the drug formularies in medical institutions?

Marco Zuin  1 , Claudio Picariello  2 , Lina Marcantoni  2 , Loris Roncon  2
Affiliations
Comment

Burden of costs associated with heparin-induced thrombocytopenia: is time to remove unfractionated heparin from the drug formularies in medical institutions?

Marco Zuin et al. Ann Transl Med. 2016 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflict of interest to declare.

Comment on

References

    1. Greinacher A. Clinical practice. Heparin-Induced Thrombocytopenia. N Engl J Med 2015;373:252-61. 10.1056/NEJMcp1411910 - DOI - PubMed
    1. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 2005;106:2710-5. 10.1182/blood-2005-04-1546 - DOI - PubMed
    1. Junqueira DR, Perini E, Penholati RR, et al. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev 2012;9:CD007557. - PubMed
    1. McGowan KE, Makari J, Diamantouros A, et al. Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program. Blood 2016;127:1954-9. 10.1182/blood-2015-07-660001 - DOI - PubMed
    1. Fowler RA, Mittmann N, Geerts W, et al. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. JAMA 2014;312:2135-45. 10.1001/jama.2014.15101 - DOI - PubMed

LinkOut - more resources